Literature DB >> 18095068

Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women.

Naoko Tsugawa1, Masataka Shiraki, Yoshitomo Suhara, Maya Kamao, Reo Ozaki, Kiyoshi Tanaka, Toshio Okano.   

Abstract

It has been reported that vitamin K supplementation effectively prevents fractures and sustains bone mineral density in osteoporosis. However, there are only limited reported data concerning the association between vitamin K nutritional status and bone mineral density (BMD) or fractures in Japan. The objectives were to evaluate the association between plasma phylloquinone (K1) or menaquinone (MK-4 and MK-7) concentration and BMD or fracture in Japanese women prospectively. A total of 379 healthy women aged 30-88 years (mean age, 63.0 years) were consecutively enrolled. Plasma K1, MK-4, MK-7, and serum undercarboxylated osteocalcin (ucOC) concentrations, BMD, and incidence of vertebral fractures were evaluated. In stepwise multiple linear regression analyses, L2-4 BMD and a bone turnover marker, log K1, concentrations were independently correlated with vertebral fracture incidence. When subjects were divided into low and high K1 groups by plasma K1 concentration, the incidence of vertebral fracture in the low K1 group (14.4%) was significantly higher than that in the high K1 group (4.2%), and its age-adjusted RR was 3.58 (95% CI, 3.26-3.93). L2-4 BMD was not different between the two groups. These results suggest that subjects with vitamin K1 insufficiency in bone have increased susceptibility for vertebral fracture independently from BMD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095068     DOI: 10.1007/s00774-007-0790-8

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  45 in total

1.  The effect of vitamin K and D supplementation on ovariectomy-induced bone loss.

Authors:  S Matsunaga; H Ito; T Sakou
Journal:  Calcif Tissue Int       Date:  1999-10       Impact factor: 4.333

2.  Association of bone mineral density with apolipoprotein E phenotype.

Authors:  M Shiraki; Y Shiraki; C Aoki; T Hosoi; S Inoue; M Kaneki; Y Ouchi
Journal:  J Bone Miner Res       Date:  1997-09       Impact factor: 6.741

3.  Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.

Authors:  Hajime Otomo; Akinori Sakai; Satoshi Ikeda; Shinya Tanaka; Masako Ito; Roger J Phipps; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

4.  Ethnic differences in osteocalcin gamma-carboxylation, plasma phylloquinone (vitamin K1) and apolipoprotein E genotype.

Authors:  S R Beavan; A Prentice; D M Stirling; B Dibba; L Yan; D J Harrington; M J Shearer
Journal:  Eur J Clin Nutr       Date:  2005-01       Impact factor: 4.016

5.  Plasma transport of vitamin K in men using deuterium-labeled collard greens.

Authors:  Arja T Erkkilä; Alice H Lichtenstein; Gregory G Dolnikowski; Michael A Grusak; Susan M Jalbert; Katherine A Aquino; James W Peterson; Sarah L Booth
Journal:  Metabolism       Date:  2004-02       Impact factor: 8.694

Review 6.  Vitamin K nutrition and osteoporosis.

Authors:  N C Binkley; J W Suttie
Journal:  J Nutr       Date:  1995-07       Impact factor: 4.798

7.  Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women.

Authors:  Masao Fukunaga; Toshitaka Nakamura; Masataka Shiraki; Tatsuhiko Kuroda; Hiroaki Ohta; Takayuki Hosoi; Hajime Orimo
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

8.  Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR.

Authors:  Michelle M Tabb; Aixu Sun; Changcheng Zhou; Felix Grün; Jody Errandi; Kimberly Romero; Hang Pham; Satoshi Inoue; Shyamali Mallick; Min Lin; Barry M Forman; Bruce Blumberg
Journal:  J Biol Chem       Date:  2003-08-14       Impact factor: 5.157

9.  Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status.

Authors:  Sarah L Booth; Ines Golly; Jennifer M Sacheck; Ronenn Roubenoff; Gerard E Dallal; Koichiro Hamada; Jeffrey B Blumberg
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045

10.  Circulating levels of vitamin K1, menaquinone-4, and menaquinone-7 in healthy elderly Japanese women and patients with vertebral fractures and patients with hip fractures.

Authors:  K Kawana; M Takahashi; H Hoshino; K Kushida
Journal:  Endocr Res       Date:  2001-08       Impact factor: 1.720

View more
  23 in total

1.  Urinary levels of cross-linked N-terminal telopeptide of type I collagen and nutritional status in Japanese professional baseball players.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Kazuhiro Uenishi; Hiromi Ishida; Yoshihiro Sato; Hideo Matsumoto
Journal:  J Bone Miner Metab       Date:  2010-02-18       Impact factor: 2.626

2.  Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials.

Authors:  Yanfu Fang; Chuanlai Hu; Xingyong Tao; Yuhui Wan; Fangbiao Tao
Journal:  J Bone Miner Metab       Date:  2011-06-15       Impact factor: 2.626

3.  A new LC-MS assay for the quantitative analysis of vitamin K metabolites in human urine.

Authors:  Matthew G McDonald; Catherine K Yeung; Aaron M Teitelbaum; Amanda L Johnson; Shinya Fujii; Hiroyuki Kagechika; Allan E Rettie
Journal:  J Lipid Res       Date:  2019-01-22       Impact factor: 5.922

4.  Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial.

Authors:  Michael F Holick; Joseph J Lamb; Robert H Lerman; Veera R Konda; Gary Darland; Deanna M Minich; Anuradha Desai; Tai C Chen; Melissa Austin; Jacob Kornberg; Jyh-Lurn Chang; Alex Hsi; Jeffrey S Bland; Matthew L Tripp
Journal:  J Bone Miner Metab       Date:  2009-12-19       Impact factor: 2.626

5.  Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).

Authors:  Shiro Tanaka; Teruhiko Miyazaki; Yukari Uemura; Tatsuhiko Kuroda; Nobuaki Miyakawa; Toshitaka Nakamura; Masao Fukunaga; Yasuo Ohashi; Hiroaki Ohta; Satoshi Mori; Hiroshi Hagino; Takayuki Hosoi; Toshitsugu Sugimoto; Eiji Itoi; Hajime Orimo; Masataka Shiraki
Journal:  J Bone Miner Metab       Date:  2013-07-05       Impact factor: 2.626

6.  Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.

Authors:  Masataka Shiraki; Akira Itabashi
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

7.  Level of serum undercarboxylated osteocalcin correlates with bone quality assessed by calcaneal quantitative ultrasound sonometry in young Japanese females.

Authors:  Yoshio Suzuki; Asako Maruyama-Nagao; Keishoku Sakuraba; Sachio Kawai
Journal:  Exp Ther Med       Date:  2017-03-09       Impact factor: 2.447

Review 8.  Osteoporosis prevention and nutrition.

Authors:  Katherine L Tucker
Journal:  Curr Osteoporos Rep       Date:  2009-12       Impact factor: 5.096

Review 9.  Integrative physiology: defined novel metabolic roles of osteocalcin.

Authors:  Yu-Sik Kim; Il-Young Paik; Young-Jun Rhie; Sang-Hoon Suh
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

10.  Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.

Authors:  Noriko Koitaya; Mariko Sekiguchi; Yuko Tousen; Yoriko Nishide; Akemi Morita; Jun Yamauchi; Yuko Gando; Motohiko Miyachi; Mami Aoki; Miho Komatsu; Fumiko Watanabe; Koji Morishita; Yoshiko Ishimi
Journal:  J Bone Miner Metab       Date:  2013-05-24       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.